title: [Uveal effusion induced by escitalopram].
abstract: METHODS
  A 73 year-old woman with depression treated with escitalopram developed acute secondary angle closure glaucoma related to uveal effusion after duplicating the drug dose 3 days before. She evolved favorably once the antidepressant treatment was suspended and a new treatment with topical hypotensive therapy and oral prednisone was used.
  
  
  CONCLUSIONS
  The uveal effusion syndrome associated to medicines is rare; it may be associated with acute myopic shift and acute angle closure glaucoma. The correct diagnosis and discontinuation of the drug lead to the resolution of this nosology.
authors.affiliation: Servicio de Oftalmología, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, España.
authors.forename: A
authors.initials: A
authors.lastname: Arias Palomero
authors.affiliation: Servicio de Oftalmología, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, España. Electronic address: javierinmol@hotmail.com.
authors.forename: E J
authors.initials: EJ
authors.lastname: Infantes Molina
authors.affiliation: Servicio de Oftalmología, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, España.
authors.forename: E
authors.initials: E
authors.lastname: López Arroquia
authors.affiliation: Servicio de Oftalmología, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, España.
authors.forename: L
authors.initials: L
authors.lastname: Riveira Villalobos
authors.affiliation: Servicio de Oftalmología, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, España.
authors.forename: E
authors.initials: E
authors.lastname: López Mondéjar
authors.affiliation: Servicio de Oftalmología, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, España.
authors.forename: F
authors.initials: F
authors.lastname: González del Valle
mesh_terms: D000208:Acute Disease; D000368:Aged; D001285:Atropine / Q000627:therapeutic use; D000068438:Brimonidine Tartrate / Q000627:therapeutic use; D015862:Choroid Diseases / Q000139:chemically induced / Q000188:drug therapy; D002924:Ciliary Body / Q000473:pathology; D015283:Citalopram / Q000009:adverse effects*; D062787:Drug Overdose; D004630:Emergencies; D005260:Female; D015812:Glaucoma, Angle-Closure / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D009216:Myopia / Q000139:chemically induced; D011241:Prednisone / Q000627:therapeutic use; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D058471:Subretinal Fluid / Q000000981:diagnostic imaging; D013999:Timolol / Q000627:therapeutic use; D014603:Uveal Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D001285:Atropine; D000068438:Brimonidine Tartrate; D015283:Citalopram; D011241:Prednisone; D011985:Receptors, Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D013999:Timolol
keywords: Acute glaucoma; Acute myopia; Antidepresivos; Antidepressants; Efusión uveal; Escitalopram; Glaucoma agudo; Miopía aguda; Uveal effusion